ONO PHARMA USA的动态

IP Philly Today! Our next session, "Patent Law: Year in Review," was moderated by The Honorable John F. Murphy with panelists John O. Hillman from BakerHostetler, Alison P. Patitucci, Ph.D. from Morgan, Lewis & Bockius LLP, Anthony David Sierra from Akin Gump Strauss Hauer & Feld LLP, and Brianna Vinci from Duane Morris LLP. Major cases such as Amgen v. Sanofi and LKQ Corp. v. GMGlobal Technology, among others, were discussed. #IPPhilly #PatentLaw

News! Former senior FTC lawyer David B. Schwartz joins our Washington D.C. office as an Antitrust & Competition partner. ? David brings extensive knowledge in antitrust law and litigation, leveraging from his experience as a former Lead Investigative Attorney at the FTC. ? Previously serving in the commission's Healthcare Division of the Bureau of Competition, he regularly advises on enforcement issues related to pharmaceutical pricing, health information technology conduct, private equity provider acquisitions, and Medicine Modernization Act patent settlements. ? Learn more about David here: https://lnkd.in/eZfu8aVd ? #Law #Antitrust #Competition #NewHire

Our Partner and Head of our Life Sciences Practice, Elvan Sevi Bozo?lu, PhD, represented our Firm, at the 10th Annual IBA World Life Sciences Conference, co-presented by the?IBA Intellectual Property and Entertainment Law Committee,?IBA Technology Law Committee?and the?IBA Healthcare and Life Sciences Law Committee, where industry speakers discuss hot topics and key developments covering the different sectors of the healthcare and life sciences industry. During her speech she emphasized the importance of balance between public health advocacy and commercial promotion and mentioned that even though countries share a common terminology approach, the interpretation of local regulatory bodies can vary significantly. #IBAMadrid?#WLCF?#LegalIndustry #pharmaceuticaladvertising?#compliance?#pharma?#lifesciences

From 9 to 11 April, the HealthPharm 2024 SEE Forum & Fair was held in Belgrade, at the event where legal, tech, and life science met. Our Partner Bojan Vuckovic was among the speakers on the second day of the conference, delving into topics surrounding the Law on Protection of Competition and its implications for public procurement. For more information about the speakers and the discussion, read our piece below. ? #HealthPharm #Competition #PublicProcurement #Conference #KaranovicPartners

Westerberg & Partners is proud to announce the publication of Life Science – Law and Practice, a practical handbook for Swedish companies in the life science industry authored by Malcolm Wiberg, Jonas L?fgren, Bj?rn Rundblom Andersson, Wendela H?rdemark, Josefine Arvebratt, Annalena Nordin and Hans Eriksson. The book is the first of its kind and is aimed at business leaders and entrepreneurs as well as researchers and others who in their daily work navigate the various complex legal and regulatory frameworks that apply to the development and trade of pharmaceuticals, medical technology products and cosmetics. For more information and to order the book (in Swedish): https://lnkd.in/drMFeZxY #LifeScience #Law #IntellectualProperty #IP Norstedts Juridik

???????????? What initiatives are geared to drive #biotech and #medtech innovation and to accelerate routes to market in the #EU? ??? The final session of the #CooleyREG Talks (EU) webinar series on October 31 is all about what biotech and medtech companies need to know. A Cooley LLP team will cover pharma and medtech regulation, medical product initiatives, preventive health initiatives, life sciences and data, and competition law enforcement.

We’re delighted to announce that the 2024 LMG Life Sciences EMEA Awards recognized Arnold & Porter’s life sciences legal work during its annual ceremony honoring the region’s most distinguished practitioners and their firms for their exemplary legal work in the life sciences sector in 2023. Arnold & Porter received the “Impact Case of the Year” award, which highlights firms involved in the most impactful case decisions made in the life sciences industry during 2023. The firm was also shortlisted for Regulatory Firm of the Year, Belgium Firm of the Year, and Netherlands Firm of the Year. To learn more about our recognition, click here ?? https://bit.ly/3VhLtCz #LifeSciences #EMEA #Regulatory

Yikes: I am lecturing at the American Intellectual Property Law Association (AIPLA) ppbc this Thursday on inequitable conduct and unclean hands. Last night, my law partner, Michelle O'Brien of The Marbury Law Group, PLLC, asked me to sub in on tomorrow's bio/chem claim drafting workshop, as our distinguished colleague, Nichole Martiak Valeyko of Merck, has fallen ill (speedy and full recovery Nichole). I don't think I can fill Nichole's big shoes, but I am hoping that the thousands and thousands of chem/bio claims I have drafted over about the last 50 years, will somehow enable me to impart useful knowledge to the participants. We shall see.

Complex guidelines across multiple countries present challenges for global teams trying to expand access to novel treatments for European patients. ? To help international biotechs successfully realize clinical testing in Europe, our colleagues, Vlada Injac (VP of Regulatory Affairs) and Istvan Horvath (VP of Corporate Legal Affairs & Intellectual Property), will share their expertise and guide you through the challenges, to ensure the success of your clinical trials. The webinar is almost here! Mark your calendars for April 30, 2024, at 9:00 AM CET. Register today to reserve your spot >>?https://lnkd.in/grBEQdZQ #webinar #clinicaltrials #clinicalresearch #legal #regulatory

?New Milestone Achievement. I am excited to share that I have successfully completed the "PatentX" certification in Patent Law and Global Public Health, awarded by World Intellectual Property Organization – WIPO and Harvard Law School. This certification enhances my understanding of the intersection between intellectual property and public health issues on a global scale. With this new qualification, I now have a complementary experience in intellectual property in addition to my background in regulatory affairs. This diverse expertise is a significant addition to my career, and I look forward to applying this knowledge to my work and continuing to contribute to this vital field. #IP #WIPO #patent #patentX #publichealth #GolbalPublicHealth #regulatory_affairs #drug_registration.